Raymond James Financial Inc Armata Pharmaceuticals, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Armata Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 1,000 shares of ARMP stock, worth $2,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000Holding current value
$2,940% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARMP
# of Institutions
29Shares Held
731KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA260KShares$764,6140.0% of portfolio
-
Geode Capital Management, LLC Boston, MA105KShares$307,3650.0% of portfolio
-
Edgewood Management LLC Greenwich, CT100KShares$294,0000.0% of portfolio
-
Bridgeway Capital Management, LLC Houston, TX44.7KShares$131,3650.0% of portfolio
-
State Street Corp Boston, MA40.3KShares$118,4820.0% of portfolio
About Armata Pharmaceuticals, Inc.
- Ticker ARMP
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,144,700
- Market Cap $106M
- Description
- Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus ...